Document
IPR2017-01726, No. 1031 Exhibit - Clark, Do we really need prognostic factors for breast cancer, 1994 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2017-01726, No. 1031 Exhibit - Clark, Do we really need prognostic factors for breast cancer, 1994 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2017-01726, No. 1003 Exhibit - Declaration of Dr Allan Lipton (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2017-01726, No. 1003 Exhibit - Declaration of Dr Allan Lipton (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2017-01726, No. 1016 Exhibit - Early stage breast cancer, NCI Dictionary of Cancer Terms, Feb 15, 2017 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2017-01726, No. 1016 Exhibit - Early stage breast cancer, NCI Dictionary of Cancer Terms, Feb 15, 2017 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2017-01726, No. 1007 Exhibit - Gradishar et al, Progress in Systemic Adjuvant Therapy of Early Stage Breast Cancer, 8 INTL JCLIN ONCOL 239 247 May 23, 2003 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2017-01726, No. 1007 Exhibit - Gradishar et al, Progress in Systemic Adjuvant Therapy of Early Stage Breast Cancer, 8 INTL JCLIN ONCOL 239 247 May 23, 2003 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2017-01726, No. 1009 Exhibit - Herceptin Trastuzumab Herceptin Product Label Sept 1998 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2017-01726, No. 1009 Exhibit - Herceptin Trastuzumab Herceptin Product Label Sept 1998 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2017-01726, No. 1005 Exhibit - Van Pelt et al, Neoadjuvant Trastuzumab and Docetaxel in Patients with Breast Cancer Preliminary Results, 4 CLIN BREAST CANCER 348 2003 (P.T.A.B. Jun...
Cite Document
IPR2017-01726, No. 1005 Exhibit - Van Pelt et al, Neoadjuvant Trastuzumab and Docetaxel in Patients with Breast Cancer Preliminary Results, 4 CLIN BREAST CANCER 348 2003 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2017-01726, No. 1013 Exhibit - J Horton, Trastuzumab Use in Breast Cancer Clinical Issues, 9 CANCER CONTROL 499 507 2002 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2017-01726, No. 1013 Exhibit - J Horton, Trastuzumab Use in Breast Cancer Clinical Issues, 9 CANCER CONTROL 499 507 2002 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2017-01726, No. 1020 Exhibit - Herceptin Trastuzumab Herceptin Product Label Revised Dec 2001, (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2017-01726, No. 1020 Exhibit - Herceptin Trastuzumab Herceptin Product Label Revised Dec 2001, (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2017-01726, No. 1011 Exhibit - Piccart Gebhart et al, Herceptin The Future in Adjuvant Breast Cancer Therapy, 12 Anti Cancer Drugs Suppl 4, S27 S33 2001 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2017-01726, No. 1011 Exhibit - Piccart Gebhart et al, Herceptin The Future in Adjuvant Breast Cancer Therapy, 12 Anti Cancer Drugs Suppl 4, S27 S33 2001 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2017-01726, No. 1015 Exhibit - Perez et al, Effect of Doxorubicin Plus Cyclophosphamide on Left Ventricular Ejection Fraction in Patients with Breast Cancer in the North Center Cancer Treat...
Cite Document
IPR2017-01726, No. 1015 Exhibit - Perez et al, Effect of Doxorubicin Plus Cyclophosphamide on Left Ventricular Ejection Fraction in Patients with Breast Cancer in the North Center Cancer Treatment Gro
+ More Snippets
Document
IPR2017-01726, No. 1014 Exhibit - Citron et al, Randomized Trial of Dose Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperat...
Cite Document
IPR2017-01726, No. 1014 Exhibit - Citron et al, Randomized Trial of Dose Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treat
+ More Snippets
Document
IPR2017-01726, No. 1002-5 Exhibit - File History of US Patent 8,591,897, Vol 5 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2017-01726, No. 1002-5 Exhibit - File History of US Patent 8,591,897, Vol 5 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2017-01726, No. 1002-9 Exhibit - File History of US Patent 8,591,897, Vol 9 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2017-01726, No. 1002-9 Exhibit - File History of US Patent 8,591,897, Vol 9 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2017-01726, No. 1001 Exhibit - US Patent 8,591,897 (P.T.A.B. Jun. 30, 2017)
Cite Document
IPR2017-01726, No. 1001 Exhibit - US Patent 8,591,897 (P.T.A.B. Jun. 30, 2017)
+ More Snippets
Document
IPR2017-01726, No. 1017-2 Exhibit - Devita et al, PRINCIPLES AND PRACTICE OF ONCOLOGY, 289 304 Principles of Cancer Management Chemotherapy, 307 333 Principles of Cancer Manag...
Cite Document
IPR2017-01726, No. 1017-2 Exhibit - Devita et al, PRINCIPLES AND PRACTICE OF ONCOLOGY, 289 304 Principles of Cancer Management Chemotherapy, 307 333 Principles of Cancer Management Biologic Therapy, 1
+ More Snippets